BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3532333)

  • 1. Preclinical biology of alpha interferons.
    Trotta PP
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):3-12. PubMed ID: 3532333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of human natural interferon-alpha and mismatched double-stranded RNA against a human renal cell carcinoma xenograft.
    Hubbell HR; Pequignot EC; Shanabrook KR; Carter WA; Williams RD; Strayer DR
    Anticancer Res; 1990; 10(3):795-801. PubMed ID: 2369093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts.
    Beniers AJ; Peelen WP; Hendriks BT; Schalken JA; Romijn JC; Debruyne FM
    Urol Res; 1988; 16(4):309-14. PubMed ID: 2459829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay.
    Welander CE; Morgan TM; Homesley HD; Trotta PP; Spiegel RJ
    Int J Cancer; 1985 Jun; 35(6):721-9. PubMed ID: 4008100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cloned human leukocyte interferons in the human tumor stem cell assay.
    Salmon SE; Durie BG; Young L; Liu RM; Trown PW; Stebbing N
    J Clin Oncol; 1983 Mar; 1(3):217-25. PubMed ID: 6686847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of human IFN-beta complex with the soluble type I interferon receptor IFNAR-2 leads to enhanced IFN stability, pharmacokinetics, and antitumor activity in xenografted SCID mice.
    McKenna SD; Vergilis K; Arulanandam AR; Weiser WY; Nabioullin R; Tepper MA
    J Interferon Cytokine Res; 2004 Feb; 24(2):119-29. PubMed ID: 14980076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options in renal-cell carcinoma.
    Krown SE
    Semin Oncol; 1985 Dec; 12(4 Suppl 5):13-7. PubMed ID: 2417331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system.
    Balkwill FR; Moodie EM
    Cancer Res; 1984 Mar; 44(3):904-8. PubMed ID: 6692412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
    Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
    Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons in the treatment of multiple myeloma.
    Cooper MR
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The history of interferon and its use in animal therapy.
    Young AS; Cummins JM
    East Afr Med J; 1990 Jul; 67(7 Suppl 2):SS31-63. PubMed ID: 2226234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha interferon in the treatment of hematologic malignancies.
    Roth MS; Foon KA
    Am J Med; 1986 Nov; 81(5):871-82. PubMed ID: 3535496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of interferon in the treatment of ovarian cancer as a single agent and in combination with cytotoxic drugs.
    Welander CE
    Cancer; 1987 Feb; 59(3 Suppl):617-9. PubMed ID: 3802026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural effects of alpha and gamma interferons and cytostatics on ovarian cancer cells in the subrenal capsule assay (SRCA).
    Söderström KO; Mäenpää J; Cantell K; Kangas L; Grönroos M
    Ann Chir Gynaecol Suppl; 1985; 199():38-43. PubMed ID: 3933399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interferon-alpha (IFN alpha) on various human tumor xenografts.
    Nagy P; Kopper L; Gyapay G; Péterfy F; Lapis K
    Anticancer Res; 1988; 8(3):467-9. PubMed ID: 3389749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological activity of human alpha-interferons studied using specific antisera].
    Korsun NS; Nosik DN; Novokhatskiĭ AS; Trushinskaia GN
    Antibiot Khimioter; 1988 Nov; 33(11):827-30. PubMed ID: 2465745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of growth inhibiting effect of natural and recombinant interferon-alpha on human osteosarcomas in nude mice.
    Bauer HC; Brosjö O; Strander H
    J Interferon Res; 1987 Aug; 7(4):365-9. PubMed ID: 3478420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activation of phagocytosis by preparations of human alpha and gamma interferons].
    Vakhrameeva NS; Avdeeva ZhE; Kuznetsov VP; Bobkova EV; Krylov OR
    Vopr Virusol; 1988; 33(2):181-4. PubMed ID: 3137727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha and gamma interferons and cytostatics on ovarian cancer in the subrenal capsule assay.
    Grönroos M; Mäenpää J; Söderström KO; Kangas L; Leppänen M; Cantell K
    Med Biol; 1983; 61(5):275-9. PubMed ID: 6200736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.